List of Tables
Table 1. Osteoarthritis Medications Market Trends
Table 2. Osteoarthritis Medications Market Drivers & Opportunity
Table 3. Osteoarthritis Medications Market Challenges
Table 4. Osteoarthritis Medications Market Restraints
Table 5. Global Osteoarthritis Medications Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Osteoarthritis Medications Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Osteoarthritis Medications Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Osteoarthritis Medications Product Type
Table 9. Key Companies Time to Begin Mass Production of Osteoarthritis Medications
Table 10. Global Osteoarthritis Medications Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Medications as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Osteoarthritis Medications Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Osteoarthritis Medications Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Osteoarthritis Medications Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Osteoarthritis Medications Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Osteoarthritis Medications Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Osteoarthritis Medications Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Osteoarthritis Medications Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Osteoarthritis Medications Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Osteoarthritis Medications Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Osteoarthritis Medications Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Osteoarthritis Medications Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Osteoarthritis Medications Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Osteoarthritis Medications Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Osteoarthritis Medications Sales Value by Region (2019-2024) & (%)
Table 27. Global Osteoarthritis Medications Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Osteoarthritis Medications Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Osteoarthritis Medications Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Osteoarthritis Medications Sales Value, (2025-2030) & (US$ Million)
Table 31. Pfizer Basic Information List
Table 32. Pfizer Description and Business Overview
Table 33. Pfizer Osteoarthritis Medications Products, Services and Solutions
Table 34. Revenue (US$ Million) in Osteoarthritis Medications Business of Pfizer (2019-2024)
Table 35. Pfizer Recent Developments
Table 36. Johnson & Johnson Basic Information List
Table 37. Johnson & Johnson Description and Business Overview
Table 38. Johnson & Johnson Osteoarthritis Medications Products, Services and Solutions
Table 39. Revenue (US$ Million) in Osteoarthritis Medications Business of Johnson & Johnson (2019-2024)
Table 40. Johnson & Johnson Recent Developments
Table 41. GlaxoSmithKline Basic Information List
Table 42. GlaxoSmithKline Description and Business Overview
Table 43. GlaxoSmithKline Osteoarthritis Medications Products, Services and Solutions
Table 44. Revenue (US$ Million) in Osteoarthritis Medications Business of GlaxoSmithKline (2019-2024)
Table 45. GlaxoSmithKline Recent Developments
Table 46. Novartis Basic Information List
Table 47. Novartis Description and Business Overview
Table 48. Novartis Osteoarthritis Medications Products, Services and Solutions
Table 49. Revenue (US$ Million) in Osteoarthritis Medications Business of Novartis (2019-2024)
Table 50. Novartis Recent Developments
Table 51. Bayer Basic Information List
Table 52. Bayer Description and Business Overview
Table 53. Bayer Osteoarthritis Medications Products, Services and Solutions
Table 54. Revenue (US$ Million) in Osteoarthritis Medications Business of Bayer (2019-2024)
Table 55. Bayer Recent Developments
Table 56. Eli Lilly Basic Information List
Table 57. Eli Lilly Description and Business Overview
Table 58. Eli Lilly Osteoarthritis Medications Products, Services and Solutions
Table 59. Revenue (US$ Million) in Osteoarthritis Medications Business of Eli Lilly (2019-2024)
Table 60. Eli Lilly Recent Developments
Table 61. Sanofi Basic Information List
Table 62. Sanofi Description and Business Overview
Table 63. Sanofi Osteoarthritis Medications Products, Services and Solutions
Table 64. Revenue (US$ Million) in Osteoarthritis Medications Business of Sanofi (2019-2024)
Table 65. Sanofi Recent Developments
Table 66. Horizon Pharma Basic Information List
Table 67. Horizon Pharma Description and Business Overview
Table 68. Horizon Pharma Osteoarthritis Medications Products, Services and Solutions
Table 69. Revenue (US$ Million) in Osteoarthritis Medications Business of Horizon Pharma (2019-2024)
Table 70. Horizon Pharma Recent Developments
Table 71. Abbott Basic Information List
Table 72. Abbott Description and Business Overview
Table 73. Abbott Osteoarthritis Medications Products, Services and Solutions
Table 74. Revenue (US$ Million) in Osteoarthritis Medications Business of Abbott (2019-2024)
Table 75. Abbott Recent Developments
Table 76. Mylan Basic Information List
Table 77. Mylan Description and Business Overview
Table 78. Mylan Osteoarthritis Medications Products, Services and Solutions
Table 79. Revenue (US$ Million) in Osteoarthritis Medications Business of Mylan (2019-2024)
Table 80. Mylan Recent Developments
Table 81. Daiichi Sankyo Basic Information List
Table 82. Daiichi Sankyo Description and Business Overview
Table 83. Daiichi Sankyo Osteoarthritis Medications Products, Services and Solutions
Table 84. Revenue (US$ Million) in Osteoarthritis Medications Business of Daiichi Sankyo (2019-2024)
Table 85. Daiichi Sankyo Recent Developments
Table 86. TEVA Basic Information List
Table 87. TEVA Description and Business Overview
Table 88. TEVA Osteoarthritis Medications Products, Services and Solutions
Table 89. Revenue (US$ Million) in Osteoarthritis Medications Business of TEVA (2019-2024)
Table 90. TEVA Recent Developments
Table 91. Almatica Pharma Basic Information List
Table 92. Almatica Pharma Description and Business Overview
Table 93. Almatica Pharma Osteoarthritis Medications Products, Services and Solutions
Table 94. Revenue (US$ Million) in Osteoarthritis Medications Business of Almatica Pharma (2019-2024)
Table 95. Almatica Pharma Recent Developments
Table 96. Astellas Pharma Basic Information List
Table 97. Astellas Pharma Description and Business Overview
Table 98. Astellas Pharma Osteoarthritis Medications Products, Services and Solutions
Table 99. Revenue (US$ Million) in Osteoarthritis Medications Business of Astellas Pharma (2019-2024)
Table 100. Astellas Pharma Recent Developments
Table 101. Tide Pharmaceutical Basic Information List
Table 102. Tide Pharmaceutical Description and Business Overview
Table 103. Tide Pharmaceutical Osteoarthritis Medications Products, Services and Solutions
Table 104. Revenue (US$ Million) in Osteoarthritis Medications Business of Tide Pharmaceutical (2019-2024)
Table 105. Tide Pharmaceutical Recent Developments
Table 106. Iroko Pharmaceuticals Basic Information List
Table 107. Iroko Pharmaceuticals Description and Business Overview
Table 108. Iroko Pharmaceuticals Osteoarthritis Medications Products, Services and Solutions
Table 109. Revenue (US$ Million) in Osteoarthritis Medications Business of Iroko Pharmaceuticals (2019-2024)
Table 110. Iroko Pharmaceuticals Recent Developments
Table 111. Hengrui Pharmaceutical Basic Information List
Table 112. Hengrui Pharmaceutical Description and Business Overview
Table 113. Hengrui Pharmaceutical Osteoarthritis Medications Products, Services and Solutions
Table 114. Revenue (US$ Million) in Osteoarthritis Medications Business of Hengrui Pharmaceutical (2019-2024)
Table 115. Hengrui Pharmaceutical Recent Developments
Table 116. Abiogen Pharma Basic Information List
Table 117. Abiogen Pharma Description and Business Overview
Table 118. Abiogen Pharma Osteoarthritis Medications Products, Services and Solutions
Table 119. Revenue (US$ Million) in Osteoarthritis Medications Business of Abiogen Pharma (2019-2024)
Table 120. Abiogen Pharma Recent Developments
Table 121. Flexion Therapeutics Basic Information List
Table 122. Flexion Therapeutics Description and Business Overview
Table 123. Flexion Therapeutics Osteoarthritis Medications Products, Services and Solutions
Table 124. Revenue (US$ Million) in Osteoarthritis Medications Business of Flexion Therapeutics (2019-2024)
Table 125. Flexion Therapeutics Recent Developments
Table 126. Anika Therapeutics Basic Information List
Table 127. Anika Therapeutics Description and Business Overview
Table 128. Anika Therapeutics Osteoarthritis Medications Products, Services and Solutions
Table 129. Revenue (US$ Million) in Osteoarthritis Medications Business of Anika Therapeutics (2019-2024)
Table 130. Anika Therapeutics Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Osteoarthritis Medications Downstream Customers
Table 134. Osteoarthritis Medications Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Osteoarthritis Medications Product Picture
Figure 2. Global Osteoarthritis Medications Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Osteoarthritis Medications Sales Value (2019-2030) & (US$ Million)
Figure 4. Osteoarthritis Medications Report Years Considered
Figure 5. Global Osteoarthritis Medications Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Osteoarthritis Medications Revenue in 2023
Figure 7. Osteoarthritis Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. NSAIDs Picture
Figure 9. Corticosteroids Picture
Figure 10. Hyaluronic Acid Injection Picture
Figure 11. Others Picture
Figure 12. Global Osteoarthritis Medications Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Osteoarthritis Medications Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospital Pharmacies
Figure 15. Product Picture of Retail Pharmacies
Figure 16. Product Picture of Online Pharmacies
Figure 17. Global Osteoarthritis Medications Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Osteoarthritis Medications Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Osteoarthritis Medications Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Osteoarthritis Medications Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Osteoarthritis Medications Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Osteoarthritis Medications Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Osteoarthritis Medications Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Osteoarthritis Medications Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Osteoarthritis Medications Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Osteoarthritis Medications Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Osteoarthritis Medications Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Osteoarthritis Medications Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Osteoarthritis Medications Sales Value (%), (2019-2030)
Figure 30. United States Osteoarthritis Medications Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Osteoarthritis Medications Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Osteoarthritis Medications Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Osteoarthritis Medications Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Osteoarthritis Medications Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Osteoarthritis Medications Sales Value by Application (%), 2023 VS 2030
Figure 36. China Osteoarthritis Medications Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Osteoarthritis Medications Sales Value by Type (%), 2023 VS 2030
Figure 38. China Osteoarthritis Medications Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Osteoarthritis Medications Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Osteoarthritis Medications Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Osteoarthritis Medications Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Osteoarthritis Medications Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Osteoarthritis Medications Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Osteoarthritis Medications Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Osteoarthritis Medications Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Osteoarthritis Medications Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Osteoarthritis Medications Sales Value by Application (%), 2023 VS 2030
Figure 48. India Osteoarthritis Medications Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Osteoarthritis Medications Sales Value by Type (%), 2023 VS 2030
Figure 50. India Osteoarthritis Medications Sales Value by Application (%), 2023 VS 2030
Figure 51. Osteoarthritis Medications Industrial Chain
Figure 52. Osteoarthritis Medications Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
